Hasil Pencarian - Kevin Larimore

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study

    Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study oleh Nicola Longo, Roberto Zori, Melissa P. Wasserstein, Jerry Vockley, Barbara K. Burton, Celeste Decker, Mingjin Li, Kelly Lau, Joy Jiang, Kevin Larimore, Janet A. Thomas

    Diterbitkan 2018-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.

    Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10. oleh Kathryn A K Finton, Kevin Larimore, H Benjamin Larman, Della Friend, Colin Correnti, Peter B Rupert, Stephen J Elledge, Philip D Greenberg, Roland K Strong

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia

    Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia oleh Timothy C. R. Prickett, Eric A. Espiner, Melita Irving, Carlos Bacino, John A. Phillips, Ravi Savarirayan, Jonathan R. S. Day, Elena Fisheleva, Kevin Larimore, Ming Liang Chan, George S. Jeha

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10.

    Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10. oleh Kathryn A K Finton, Della Friend, James Jaffe, Mesfin Gewe, Margaret A Holmes, H Benjamin Larman, Andrew Stuart, Kevin Larimore, Philip D Greenberg, Stephen J Elledge, Leonidas Stamatatos, Roland K Strong

    Diterbitkan 2014-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trialsResearch in context

    Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trialsResearch in context oleh Soumi Gupta, Kelly Lau, Cary O. Harding, Gillian Shepherd, Ryan Boyer, John P. Atkinson, Vijaya Knight, Joy Olbertz, Kevin Larimore, Zhonghu Gu, Mingjin Li, Orli Rosen, Stephen J. Zoog, Haoling H. Weng, Becky Schweighardt

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria

    Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria oleh Yulan Qi, Gina Patel, Joshua Henshaw, Soumi Gupta, Joy Olbertz, Kevin Larimore, Cary O. Harding, Markus Merilainen, Roberto Zori, Nicola Longo, Barbara K. Burton, Mingjin Li, Zhonghua Gu, Stephen J. Zoog, Haoling H. Weng, Becky Schweighardt

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: